Table 2.
The level of erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and cytokines in populations.
| Healthy controls (n = 30) | Disease controls (n = 20) | HLA-B27-negative patients (n = 22) | HLA-B27-positive patients (n = 38) | |
|---|---|---|---|---|
| TNF-α (pg/ml) | 15·25 ± 2·65 | 147·79 ± 70·93** | 129·30 ± 50·55** | 290·62 ± 223·29** |
| IL-12 (pg/ml) | 4·39 ± 0·78 | 4·50 ± 1·54 | 5·43 ± 0·60** | 5·67 ± 0·78** |
| sTRAIL (pg/ml) | 936·99 ± 239·53 | 1067·01 ± 280·93 | 1474·16 ± 329·40** | 1537·66 ± 214·99** |
| ESR | 7·25 ± 3·68 | 41·90 ± 19·10** | 30·82 ± 18·16 | 46·47 ± 18·53 |
| CRP | 5·38 ± 2·99 | 37·04 ± 25·74** | 6·18 ± 3·27 | 46·01 ± 14·45** |
**
P < 0·01 versus healthy controls. HLA: human leucocyte antigen; TNF: tumour necrosis factor; IL: interleukin; sTRAIL: soluble tumour necrosis factor-related apoptosis-inducing ligand.